Sfoglia per AUTORE
VENUTI F
Collezione ASL Città di Torino

  

Items : 8

Prescription habits and drugs accessibility for the treatment of non-tuberculous mycobacteria infections in Italy: a multicentric survey from the IRENE study group. in Infection / Infection. 2024 Sep 20. doi: 10.1007/s15010-024-02390-y.

2024
ASL Asti
ASL Città di Torino

Aliberti S; Codecasa L; Blasi F; Gori A; Spotti M; Cinnirella G; Venuti F; Lupia T; Gaviraghi A; Calcagno A; Stroffolini G;

Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.

2024
ASL Città di Torino

Calcagno A; D'Avolio A; Ponzetta L; Marinaro L; Alladio F; Cat Genova E; Quaranta M; Stroffolini G; Gaviraghi A; de Nicolò A; Venuti F;

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460.

2023
ASL Città di Torino
ASL Asti

Bonora S; Calcagno A; Frascione PMM; De Rosa FG; Gregorc V; Pepe A; Ponzetta L; Vita D; Allice T; Lupia T; Ranzani FA; Venuti F; Gaviraghi A; Longo BM;

18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. in The Journal of infection / J Infect. 2023 Nov;87(5):462-464. doi: 10.1016/j.jinf.2023.03.013. Epub 2023 Mar 17.

2023
ASL Città di Torino
ASL Asti

Penna D; Piccioni P; Venuti F; Botto C; Trezzi M; Betti M; Sestini S; Erba PA; Lupia T; Di Perri G; Aliberti S; Calcagno A; Stroffolini G; Gaviraghi A;

Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214.

2023
ASL Città di Torino

Bonora S; Calcagno A; Marchiaro C; D'Avolio A; Cinnirella G; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Stroffolini G; Gaviraghi A; Longo BM; De Nicolò A; Venuti F;

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.

2022
ASL Città di Torino

Venuti F; Ghisetti V; Longo B; Staffilano E; Alladio F; Trunfio M; Richiardi L; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;

Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. in Viruses / Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.

2021
ASL Città di Torino

Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A;

On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.

2021
ASL Città di Torino

Longo BM; Trunfio M; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;